AIHTA - Publications - Search - Enfortumab vedotin (Padcev®) as monotherapy for the treatment of patients with locally advanced or metastatic urothelial cancer

Wolf, S. (2022): Enfortumab vedotin (Padcev®) as monotherapy for the treatment of patients with locally advanced or metastatic urothelial cancer. Oncology Fact Sheet Nr. 85.

[thumbnail of Oncology Fact Sheet Nr.85.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
119kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WJ Urogenital system > WJ 400-600 Ureter. Bladder. Urethra
Language:English
Series Name:Oncology Fact Sheet Nr. 85
Deposited on:28 Mar 2022 12:50
Last Modified:16 May 2022 09:33

Repository Staff Only: item control page